Volastra Therapeutics is pioneering novel approaches to halt or prevent cancer metastasis, one of the major unsolved challenges in cancer treatment. Co-founders Lewis Cantley, Ph.D., Olivier Elemento, Ph.D. and Samuel Bakhoum, M.D., Ph.D., made seminal discoveries about the role of chromosomal instability in driving cancer spread. Volastra is built on those insights. Based in West Harlem, N.Y., Volastra is committed to improving outcomes for people living with cancer.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/06/21 | $12,000,000 | Seed |
Catalio Capital Management Vida Ventures | undisclosed |
